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.2012.07.0Abstract Background: Medication errors in hospitals are a worldwide concern. The World Health
Organization has recommended the implementation of basic applications in healthcare systems to
improve medication safety, but it is largely unknown whether these recommendations are adhered
to by hospitals. We assessed the presence of core medication safety practices in Saudi Arabian hos-
pitals.
Methods: We developed and validated a survey to assess medication safety practices in hospitals.
Major headings included Look-Alike Sound-Alike (LASA) medications, control of concentrated
electrolyte solutions, transitions in care, information technology, drug information and other med-
ication safety practices. Trained pharmacists visited samples of hospitals from all regions of Saudi
Arabia.
Results: Seventy-eight hospitals were surveyed. Only 30% of the hospitals had a medication
safety committee and 9% of hospitals had a medication safety ofﬁcer. Only 33% of hospitals
had a list of LASA medications and 50% had a list of error-prone abbreviations. Concentrated elec-
trolytes were available in ﬂoor stock in 60% of the hospitals. No hospital involved pharmacists in
obtaining medication histories and only 37% of the hospitals provided a medication list to theirector of Medication Safety
ademic Affairs, College of
. Box 2475, Riyadh 11451,
(H. Aljadhey).
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160 H. Aljadhey et al.patients at discharge. While 61% of hospitals used a computer system in their pharmacy to enter
prescriptions, only 29% of these hospitals required entry of patient’s allergies before entering a drug
order.
Conclusions: Core practices to improve medication safety were not implemented in many hospi-
tals in Saudi Arabia. In developing countries, an effort must be made at the national level to
increase the adoption of such practices.
ª 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Medication errors occurring in hospitals have become a world-
wide concern for healthcare policy makers, professionals and
the public. These errors harm at least 1.5 million United States
residents annually, and treating injuries caused by these errors
cost at least 3.5 billion dollars (Aspden et al., 2006). In one
U.S. study in two academic hospitals, the incidence of adverse
drug events (ADEs) for hospitalized patients was estimated to
be 6.5 per hundred admissions (Bates et al., 1995). A more re-
cent study in community hospitals found an even higher rate of
ADEs of 15 per hundred admissions (Hug et al., 2010). In Aus-
tralia, up to 4% of all hospital admissions are medication-
related (Runciman et al., 2003). In Saudi Arabia, two recent
studies estimated that the prevalence of prescribing errors in
hospital inpatient ranges between 13 and 56 per 100 medica-
tion orders (Al-Dhawailie, 2011; Al-Jeraisy and M., 2011).
These data suggest that medication safety is an important
international contributor to morbidity and costs of healthcare.
In the past decade, research has shown that many interven-
tions could decrease the frequency of medication errors. Many
of these interventions include the use of information technol-
ogy and automation, while others use other approaches such
as involving a pharmacist with the medical team or the appli-
cation of core practices aimed at preventing ADEs (Aspden
et al., 2006; Bates et al., 1998; Poon et al., 2006; Cohen
et al., 2005; Vira et al., 2006; Gleason et al., 2004; Cavin and
Sen, 2005; Nester and Hale, 2002; Bond et al., 2000, 1999,
2002; McFadzean et al., 2003; Tam et al., 2005; Strunk
et al., 2008). For example, the use of computerized physician
order entry reduced the serious medication error rate by
55% (Bates et al., 1998) and the use of bar-code technology
minimized the rate of dispensing errors by 31% (Poon et al.,
2006). One study suggested that having a medication safety
ofﬁcer in the hospital may be associated with a lower rate of
ADEs (Cohen et al., 2005). Also, studies repeatedly show that
ascertaining a patient’s medication history at admission by a
pharmacist decreases medication errors (Vira et al., 2006;
Gleason et al., 2004; Cavin and Sen, 2005; Nester and Hale,
2002; Bond et al., 2000, 1999, 2002; McFadzean et al., 2003;
Tam et al., 2005; Strunk et al., 2008).
Though research has shown the value of these interventions
in reducing medication error rates, the extent to which they are
implemented in hospitals around the world is poorly under-
stood. In 2005, the World Health Organization (WHO)
launched the World Alliance for Patient Safety. In 2007, the
Alliance recommended patient safety solutions to help prevent
medication errors and adverse events. Adherence to the
recommendations of the WHO regarding medication safety
practices by hospitals is unknown. No study had previously
been conducted in Saudi Arabia to assess the current state ofmedication safety practices in hospitals. Understanding the
current status of activities and practices would guide policy
makers and healthcare professionals on areas for improve-
ment. The aims of the current study were to assess the presence
of core medication safety practices in Saudi Arabian hospitals
and assess the association between safety practices and
hospital characteristics.2. Methods
2.1. Design and setting
In Saudi Arabia, hospitals are either governmental or private.
Governmental hospitals can be classiﬁed as either Ministry of
Health or non-Ministry of Health hospitals. Healthcare in rur-
al areas is provided mainly by the Ministry of Health which
runs more than 220 hospitals in all regions of Saudi Arabia.
Other governmental hospitals include National Guard hospi-
tals, armed forces hospitals, security forces hospitals and spe-
cialized hospitals. Private hospitals have increased in number
and size over the past few years and are mainly concentrated
in major cities.
To obtain a national estimate of the frequency of imple-
mentation of medication safety practices in hospitals, we strat-
iﬁed hospitals by region and type, and then a convenient
sampling technique was applied. Saudi Arabia was divided
into ﬁve regions (central, north, south, east and west). We se-
lected stratiﬁed convenient samples of hospitals from each re-
gion in three categories: Ministry of Health hospitals, other
government hospitals, and private hospitals. Hospitals from
large cities and small towns were studied. The study was ap-
proved by the Medication Safety Research Chair committee
and an approval was obtained from each hospital before sur-
vey completion.
2.2. Survey administration
Pharmacists interviewed the pharmacy director or inpatient
supervisor to complete the survey. Interviewers were trained
by one of the study investigators on medication safety elements
and each section of the survey was explained in detail. Between
March and June 2009, trained pharmacists visited conveniently
selected hospitals in all regions of Saudi Arabia. Prior to visit-
ing a hospital, a fax was sent which was followed by a phone
call to the pharmacy director to schedule a meeting to com-
plete the survey. At the beginning of the meeting, the pharma-
cists explained the purpose of the study and assured that the
name of the hospital would be kept conﬁdential. Then, phar-
macists obtained answers to the survey’s questions during a
1 h meeting.
Table 1 General characteristics of surveyed hospitals.
Factor *Number of Hospitals N (%)
Region:
Center 15 (19)
East 16 (21)
West 16 (21)
South 14 (18)
North 17 (22)
Types of hospitals:
Ministry of Health 38 (49)
Government non-Ministry of Health 14 (18)
Private 26 (33)
Number of beds:
Fewer than 100 beds 16 (21)
100–299 beds 32 (42)
300–499 beds 19 (25)
500 beds and over 9 (12)
* Total number of hospitals 78 hospitals.
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A survey to assess the presence of core medication safety prac-
tices in hospitals was developed based on the recommenda-
tions of the WHO patient safety solutions, the Joint
Commission International, and the Institute for Safe Medica-
tion Practices (WHO, 2011; ISMP, 2011; JCI, 2011). We
selected common core practices that we believed were most
important for improving the safety of medications in hospitals,
and could be feasibly implemented soon in nearly all hospitals
in Saudi Arabia. The survey instrument underwent a face
validity check with a number of pharmacists to ensure that
the questions were understood. The ﬁnal version of the survey
contained 44 questions under seven main sections.
2.4. Survey content
Hospital name and contact information were collected at the
beginning of the survey. Participant hospitals were asked in
the ﬁrst part of the survey if they had a medication safety com-
mittee or subcommittee, a medication safety director, an error
reporting system and whether the error reporting system was
electronic or paper.
The second part focused on the practices to prevent medi-
cation errors because of Look-Alike Sound-Alike (LASA)
medications. Hospitals were asked if they have an updated list
of LASA medications, mechanisms to prevent errors from
LASA medications and were asked if they provide education
to healthcare professionals about these medications.
The third part consisted of three questions regarding the
hospital’s policy in dealing with concentrated electrolyte solu-
tions. It asked whether they keep concentrated electrolyte solu-
tions in ﬂoor stock, require a second person to check the
prepared solutions and include high risk warnings on the labels
of diluted electrolyte solutions.
Ten questions on practices during transitions in care were
included in the fourth section. The questions included whether
the hospital ascertains a complete medication history and, if
so, who conducts the history, and if the current medications
list is kept in a highly visible location. Surveyed hospitals were
also asked whether they have written policies regarding listing
and updating medication lists, updating the current medication
list when new orders are written, providing patients with lists
of discharged medications, and educating healthcare profes-
sionals about medication reconciliation when health care tran-
sitions occur for patients.
The ﬁfth section assessed the use of health information
technology in patient care. Questions included whether phar-
macists have electronic access to inpatient and outpatient lab-
oratory values and if a medication bar-coding system is used to
verify drug orders. Interviewers also asked whether the hospi-
tal has an electronic medication administration record and if
patient allergy information is required before entering a pre-
scription order.
The last two sections of the survey asked about the
availability of drug information resources and the imple-
mentation of other practices. These practices included the
use of maximum doses for high-alert drugs, implementation
of a controlled drug formulary system, the presence of a
list of error-prone abbreviations and the use of a unit dose
system.2.5. Statistical analysis
Descriptive statistics were performed to illustrate the results of
the survey. Results are displayed as counts and percentages.
Univariate analysis using chi-square test or ﬁscher’s exact test
as appropriate was used to assess the association between the
presence of important medication safety practices and the pres-
ence of medication safety ofﬁcer, medication safety committee,
or hospital size. We considered a p value < 0.05 as statistically
signiﬁcant. The Statistical Package for Social Science (SPSS)
for windows version 14 (SPSS Inc., Chicago, IL, USA) was
used for analysis.
3. Results
Seventy-eight hospitals were surveyed; 38 (49%) were Ministry
of Health hospitals, 14 (18%) were governmental non-Minis-
try of Health hospitals and 26 (33%) were private hospitals
(Table 1). Most of the hospitals had a capacity of 100–299
beds.
Only 22 (28%) hospitals had a medication safety committee
and 7 (9%) hospitals had a medication safety ofﬁcer (Table 2).
More than 50% of the hospitals did not have a list of LASA
medications, a mechanism to review LASA medications and
did not include brand and generic names on the labels of
medications.
Concentrated electrolytes (potassium chloride, potassium
phosphate, magnesium sulfate and parenteral sodium chloride
solutions with concentrations greater than 0.9%) were avail-
able in ﬂoor stock in 47 (60%) hospitals. High risk warning la-
bels were applied on diluted electrolyte solutions in only 34%
of the hospitals. More than 40% of the hospitals did not dou-
ble-check ﬁnal concentrations of prepared electrolyte solutions
including calculations.
None of the hospitals involved pharmacists to ascertain
patients’ medication histories and only 27 (37%) hospitals
provided patients with a list of medications at discharge.
A unit dose system was implemented in 70 (90%) hospitals
and computerized drug information resources were available
in the pharmacies of 33 (43%) hospitals. Forty-ﬁve (61%)
Table 2 Medication safety practices in Saudi Arabia hospitals.
Factor *Number of Hospitals N (%)
Medication Safety Committee and error reporting systems
Medication safety committee 22 (28)
Medication safety director 7 (9)
Paper-based error reporting system used 59 (76)
Electronic error reporting system implemented 6 (12)
Look-Alike sound-Alike (LASA) medications
List (LASA) medications 26 (33)
Mechanism for reviewing LASA medications 20 (47)
Mechanism to prevent LASA medications 35 (57)
Education on LASA medications 38 (50)
Medications stored in pharmacy alphabetically 57 (73)
Diagnosis ﬁeld exists in the prescription or drug order 73 (95)
Both brand and generic names included on medication labels 20 (27)
Control of concentrated electrolyte solution
Concentrated electrolytes found on ﬂoor stock 47 (60)
Second person veriﬁes ﬁnal concentrations of parenteral electrolyte solutions including calculations 39 (53)
High-risk warning label used on diluted electrolyte solution 26 (34)
Transition in care
New order required with patient admission or transfer 46 (59)
Orders ‘‘resume the same medications’’ are accepted 44 (56)
Policy to update medication list exists 52 (70)
Complete drug history taken 71 (95)
Pharmacist takes medication history 0
Current medications list put in consistent highly visible location 61 (81)
Written policies and procedures to list and update the medication list 41 (57)
Current medication list updated with new physician orders 62 (83)
List of discharge medications 27 (37)
Health care professionals educated on procedures for reconciling medications 18 (24)
Information Technology
Electronic access to inpatient laboratory values 34 (44)
Medication bar coding 9 (12)
Electronic medication administration record 21 (29)
Pharmacy uses computer to enter prescription 45 (61)
Patient allergy history is required to enter an order 13 (39)
Drug allergy veriﬁed 24 (55)
Pharmacy computer screens drug for drug allergy 13 (29)
Allergy list is clearly visible on all pages of medication administration records 53 (77)
Computer is directly interfaced with the laboratory 10 (14)
Body weight is a required ﬁeld 8 (11)
Drug Information
Drug information resources in all patient care areas 47 (61)
Computerized drug information resources in the pharmacy 33 (43)
Other Medication Safety Practices
Renal or hepatic dosage adjustment for relevant patients 18 (24)
Maximum dose for high alert drug 20 (27)
Controlled drug formulary system 57 (75)
A list of error prone abbreviations is available 38 (50)
Unit dose system implemented 70 (93)
Medications brought from home by patient are not used 60 (83)
Discontinued medications are removed from patient supplies in a timely manner 62 (86)
Pharmacy staﬀ receive baseline competency evaluation 42 (56)
*Total number of hospitals = 78.
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scriptions but only 39% of these hospitals required patient
allergy information before entering a drug order.
Other more advanced practices were also poorly imple-
mented, such as pharmacist electronic access to inpatient lab-
oratory data, use of medication bar-coding including roboticdispensing and electronic medications administration records.
It was uncommon for a pharmacist to be involved in renal
or hepatic dosage adjustment (24%) for relevant patients.
We examined the association between the presence of med-
ication safety ofﬁcer, medication safety committee, or number
of beds and the presence of important medication safety
Table 3 Association between important medication safety practices and hospital characteristics (presence of medication safety ofﬁcer
and medication safety committee).
Variable Presence of medication safety oﬃcer P value (v2 test or Fisher’s Exact test)
Yes n (%) No n (%)
List of error prone abbreviation Yes n (%) 7 (100) 31 (44.9) 0.012
No n (%) 0 38 (55.1)
List of discharge medication Yes n (%) 4 (57.1) 23 (34.8) 0.245
No n(%) 3 (42.9) 43 (65.2)
List of LASA medications Yes n (%) 7 (100) 18 (25.7) <0.001
No n (%) 0 52 (74.3)
Presence of medication safety committee
List of error prone abbreviation Yes n (%) 18 (81.8) 20 (38.5) 0.001
No n (%) 4 (18.2) 32 (61.5)
List of discharge medication Yes n (%) 13 (59.1) 14 (28) 0.018
No n (%) 9 (40.9) 36 (72)
List of LASA medications Yes n (%) 14 (63.6) 11 (20.8) 0.001
No n (%) 8 (36.34) 42 (79.2)
Table 4 Association between important medication safety practices and hospital size.
Number of beds P value (v2 test or
Fisher’s Exact test)
Fewer than 100
beds (%)
100–299
beds (%)
300–499
beds (%)
500 beds
and over
List of error prone
abbreviation
Yes n (%) 4 (25) 18 (58.1) 10 (52.6) 6
(66.7)
0.119
No n (%) 12 (75) 13 (41.9) 9 (47.4) 3
(33.3)
List of discharge
medication
Yes n (%) 4 (26.7) 10 (33.3) 6 (33.3) 7
(77.8)
0.078
No n (%) 11 (73.3) 20 (66.7) 12 (66.7) 2
(22.2)
List of LASA
medications
Yes n (%) 3 (18.8) 11 (34.4) 7 (36.8) 4
(44.4)
0.553
No n (%) 13 (81.2) 21 (65.6) 12 (63.2) 5
(55.6)
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a medication safety ofﬁcer or committee within a hospital was
highly associated with the presence of a list of error prone
abbreviations and LASA list.4. Discussion
We assessed the presence of core medication safety practices
in Saudi Arabian hospitals, and found that, there was sub-
stantial opportunity for improvement, even for relatively
low-cost interventions. Only 30% of the hospitals had a
medication safety committee and 9% had a medication
safety ofﬁcer. Furthermore, only 33% of the hospitals carry
a list of LASA medications and 50% had a list of error-
prone abbreviations. Concentrated electrolytes were available
as ﬂoor stock in 60% of hospitals. None of the hospitals in-
volved pharmacists to ascertain patients’ medication history
and only 37% of hospitals provided patients with a list of
medications at discharge.All of the above interventions can be implemented with a
relatively modest increase in resources allocated, and while this
remains to be demonstrated, they might well pay for them-
selves. Further improvement in medication safety might be ex-
pected with the implementation of other more costly solutions
such as computer order entry and bar-coding, but the basic
interventions should be implemented ﬁrst.
The results of this study have important implications on
practice in other developing countries similar to Saudi Arabia.
Action should be taken by the healthcare professionals and
hospital administrators to implement low cost practices. These
practices include lists of LASA medications, lists of discharge
medications and lists of prohibited abbreviations. None of the
surveyed hospitals involved pharmacists to obtain medication
histories. However, previous studies show that inconsistencies
in medication histories occur in up to 61% of patients admit-
ted to hospitals (Vira et al., 2006; Gleason et al., 2004; Cavin
and Sen, 2005; Nester and Hale, 2002; Bond et al., 2000,
1999, 2002; McFadzean et al., 2003; Tam et al., 2005) and
pharmacists could help to signiﬁcantly reduce these errors by
164 H. Aljadhey et al.obtaining the patients’ medication history at the time of hospi-
tal admission (Strunk et al., 2008).
When hospitals are preparing for accreditation they will
implement many practices required for accreditation, which
in turn will improve the safety of medication practices in these
hospitals. However, not all countries require that hospitals ob-
tain national or international accreditation. In Saudi Arabia,
accreditation was not required for hospitals until the establish-
ment of the Central Board of Accreditation for Healthcare
Institutions (CBAHI) in 2006. Pharmacy standards for CBA-
HI included most of the practices included in the current study.
One may argue that to beneﬁt from these practices education
and culture change are also essential, which is unlikely to be
gained by accreditation alone. Future studies need to focus
on changing the culture and studying the reasons for not
implementing medication safety practices in hospitals.
In Saudi Arabia, a national center to address medication
safety is needed to focus on research and work collaboratively
with CBAHI and various health care systems. This center
could evaluate innovative interventions, including their cost-
effectiveness, disseminate knowledge and assist in implement-
ing applications to improve the safe use of medications.
Because resources are scarce in developing countries, it is espe-
cially important to determine which interventions have the
most impact, although some such as removal of concentrated
electrolyte solutions from ﬂoor stock should simply be imple-
mented. Installation of state-of-the-art applications in a partic-
ular hospital does not automatically result in a safer
environment for patients in that hospital.
This study has several limitations. The responses of phar-
macy directors to the survey were not veriﬁed. Such veriﬁca-
tion for the presence of practices would require inspection of
the pharmacy which was not welcomed by most hospitals.
Another limitation was that the survey asked general questions
regarding the presence of certain practices and we did not
ascertain the details about each practice.
In summary, core practices to ensure medication safety
were not implemented in many hospitals in Saudi Arabia. To
improve the safe use of medications in developing countries,
an effort at a national level is needed in hospitals and this
effort should include standards, certiﬁcation, regulation, and
support for research, regulation and education.Acknowledgements
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